MiTF/TFE translocation renal cell carcinoma (tRCC) is a rare and aggressive subtype of RCC representing the most prevalent RCC in the pediatric population (up to 40%) and making up 4% of all RCCs in adults. Here, MITF is linked to renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.